5

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: January 28, 2014
Period of Report: December 31, 2013
Accession Number: 0001514955-14-000001

View Document ↗ View on SEC.gov ↗